Bad Science Used to Support Regulations
Drs. S. Stanley Young and Warren Kindzierski explored the reproducibility crisis in scientific research, specifically how unreliable studies influence...
Jon Napitupulu
ACTG Presents Data from MPOX Study STOMP at CROI
The AIDS Clinical Trials Group (ACTG) presented data from the STOMP trial at the 2025 Conference on Retroviruses and...
Rakovina’s AI Cancer Treatment Enters Preclinical Trials
Rakovina Therapeutics has received its first synthesized batch of AI-generated ATR inhibitor compounds, developed in partnership with Variational AI....
CLENE CNM-Au8® Shows ALS Survival Benefit
Clene Inc. announced positive results from a new analysis of the HEALEY ALS Platform Trial data. The analysis showed...
Revolutionizing MSI Cancer Diagnosis with €1.6M Seed Funding
MSInsight, a precision oncology start-up, secured €1.6 million in seed funding from Calyseed, angel investors, and banking partners including...
Valo Therapeutics Announces EUR 19M Investment and Expanded Trials
Valo Therapeutics Oy secured €19 million in funding to advance the clinical development of its lead cancer immunotherapy candidate,...
Neflamapimod Shows Promise in Dementia with Lewy Bodies Study
CervoMed announced positive 16-week results from the extension phase of its Phase 2b RewinD-LB study of neflamapimod for dementia...
ACTG Reveals Promising SLIM Liver Findings at CROI
The AIDS Clinical Trials Group (ACTG) presented findings from their SLIM LIVER study at the 2025 Conference on Retroviruses...
Eradivir’s EV25 Flu Challenge Study in Healthy Adults
Eradivir, a clinical-stage immunotherapy company, launched a Phase 2 challenge study for its antiviral therapeutic, EV25, to evaluate its...
4DMT Announces First Patients in Phase 3 Trial of 4D-150 for Wet AMD
4D Molecular Therapeutics (4DMT) has initiated its Phase 3 clinical trial, 4FRONT-1, for 4D-150, a potential treatment for wet...